Clinical Trials Logo

Blood Sugar; High clinical trials

View clinical trials related to Blood Sugar; High.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06333496 Active, not recruiting - Obesity Clinical Trials

Effect of a Glucagon Like Peptide 1 (GLP1) Booster in Healthy Humans

Start date: January 2, 2024
Phase: N/A
Study type: Interventional

BACKGROUND GLP1 booster (GB) was designed to stimulate the endogenous production of GLP1, which in turn releases insulin, controls blood glucose level, suppresses appetite and thus helps people lose weight. PURPOSE The purpose of this study is to assess several clinical endpoints and questionnaires in healthy volunteers taking the new GB formula. SCOPE The scope of this protocol covers the non-clinical portion as well as the assessment of several clinical endpoints and questionnaires. In brief, the non-clinical design will be an open-label study involving volunteers taking GB everyday for 12 weeks. Data analysis will involve measuring the clinical endpoints across the group at different timepoints.

NCT ID: NCT06150495 Active, not recruiting - Clinical trials for Diabetic Retinopathy

Glycemic Control and Retinal Microvascular Changes

Start date: January 1, 2019
Phase:
Study type: Observational

The goal of this prospective, observational study is to compare in the association of glycemic control and retinal microvascular changes in patients with type 2 diabetes mellitus (T2DM) without diabetic retinopathy (DR). The main question it aims to answer are: • Do degenerative changes in retinal microvasculature or nerves depend on glycemic control even before diabetic retinopathy is detected? Participants will receive an annual routine comprehensive examination including ultra-widefield fundus photography, spectral domain optical coherence tomography (OCT), and swept-source optical coherence tomography angiography (OCTA).